logo-loader

Bannerman Resources' managing director shares expert insights on uranium market

Published: 02:54 19 Jun 2018 EDT

Bannerman Resources Ltd (ASX:BMN; NSX:BMN) managing director Brandon Munro speaks to Proactive Investors about the company's Etango Uranium Project in Namibia, and also provides insights on the wider uranium market.

The company completed a Definitive Feasibility Study (DFS) on the Etango Project in 2012, which it is currently in the process of updating. Several de-risking and optimisation initiatives have been completed in the meantime.

"It will be a top-10 producing mine in the world once it's up and running, and its also very simple. Technically it's very simple, it's an open pit, low stripping ratio project, it enjoys all of the efficiencies of being a very large bulk mining operation. And we're quite unique in that we can process our ores through a low cost heap leaching operation.... arguably we're the most developed project in the world that isn't already in construction,” says Munro.

Earlier this month, Bannerman Resources raised $8 million in a heavily oversubscribed placement at 4.6 cents. Munro explains, "in undertaking the raise we really had two objectives. One was to try and improve the quality of our register, try and ascertain if there was institutional interest out there, and if so try and build our register with that, and we certainly achieved that and we're extremely happy with how that went. But secondly, with $8 million, because of all the advanced study work that we've done over the years on our project, what that means is we're now fully funded all the way to an investment decision."

Speaking about the global uranium market in general, Munro says, “it’s a very interesting position that we’re in in the market. Yes, the spot price has ticked up a little, but I would still describe it as being in a situation of inertia. The spot price certainly hasn’t responded to the market fundamentals that we’re seeing unfolding… We’re moving from surplus into deficit, and that inflection point in itself is very insignificant for a commodity, but when you start to look at what’s coming literally around the corner, developments that are happening in days and weeks at the moment, you start to realise that not only are we inflecting from surplus to deficit, we’re moving into a very deep deficit over the next few years… From a prospective producer who is very well advanced, who has an excellent technical basis to their project, that optionality is boosted enormously by the volatility that we would expect from this pricing inertia.”

Xeris Biopharma Surpasses 2023 Expectations with Strategic Moves Poised for...

Xeris Biopharma CEO Paul Edick joined Steve Darling from Proactive to share news the company had a successful 2023, with a final tally of 164 million USD, which is at the upper end of their forecast. The company concluded the year with 72 million USD in cash, surpassing their initial projections...

7 hours, 26 minutes ago